HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armando E Gonzalez Selected Research

oxfendazole

4/2021Efficacy of two locally produced oxfendazole formulations for the treatment of cysticercosis in naturally infected pigs.
10/2020Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.
1/2019Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.
1/2019Oxfendazole: a promising agent for the treatment and control of helminth infections in humans.
1/2018Barriers to Participation in a Community-Based Program to Control Transmission of Taenia solium in Peru.
1/2016Evaluation of activity of triclabendazole against Taenia solium metacestode in naturally infected pigs.
3/2015Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies.
8/2012Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.
2/2010Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
3/2009Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armando E Gonzalez Research Topics

Disease

35Cysticercosis
04/2021 - 10/2003
26Cysts
11/2021 - 10/2003
24Neurocysticercosis
01/2022 - 10/2002
18Infections
01/2022 - 09/2004
12Taeniasis
01/2021 - 10/2003
8Echinococcosis (Hydatid Cysts)
12/2015 - 10/2003
7Inflammation (Inflammations)
01/2020 - 10/2003
6Seizures (Absence Seizure)
11/2021 - 10/2002
2Parasitic Diseases (Parasitic Disease)
01/2019 - 06/2005
2Body Weight (Weight, Body)
01/2019 - 01/2016
2Cestode Infections (Tapeworm Infection)
10/2014 - 06/2004
1Persistent Infection
01/2022
1Central Nervous System Cysts (Suprasellar Cyst)
01/2022
1Hepatic Echinococcosis
01/2019
1Trematode Infections (Fasciolopsiasis)
01/2019
1Alopecia (Baldness)
01/2019
1Lymphoma (Lymphomas)
03/2015
1Epilepsy (Aura)
02/2014
1Central Nervous System Infections (Central Nervous System Infection)
08/2012
1Fascioliasis
03/2012
1Encephalitis (Encephalitis, Rasmussen)
06/2006
1Cicatrix (Scar)
10/2003
1Intracranial Hypertension
10/2002

Drug/Important Bio-Agent (IBA)

22AntigensIBA
01/2022 - 10/2003
17EnzymesIBA
01/2022 - 09/2004
17Antiparasitic Agents (Antiparasitics)IBA
01/2022 - 10/2002
16AntibodiesIBA
01/2018 - 10/2003
11oxfendazoleIBA
04/2021 - 09/2004
9Albendazole (Albenza)FDA Link
11/2021 - 01/2004
9Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2004
8Praziquantel (Biltricide)FDA Link
11/2019 - 02/2010
7ImmunosorbentsIBA
01/2022 - 09/2004
7Glycoproteins (Glycoprotein)IBA
01/2019 - 09/2004
7lentil lectinIBA
01/2019 - 09/2004
6AnthelminticsIBA
10/2020 - 03/2015
5brain synaptic membrane glycoprotein gp 50 (GP50)IBA
01/2019 - 01/2010
5VaccinesIBA
12/2012 - 10/2003
4NiclosamideFDA Link
01/2021 - 03/2004
4Pharmaceutical PreparationsIBA
11/2017 - 03/2012
4Evans Blue (Blue, Evans)FDA Link
11/2017 - 01/2014
4ChemokinesIBA
03/2015 - 09/2005
4Recombinant ProteinsIBA
05/2014 - 06/2004
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 01/2004
2benzimidazoleIBA
10/2020 - 01/2019
2Monoclonal AntibodiesIBA
01/2019 - 03/2009
2GadoliniumIBA
06/2017 - 01/2016
2CytokinesIBA
03/2015 - 02/2012
2Peptides (Polypeptides)IBA
05/2014 - 06/2012
2Anticonvulsants (Antiepileptic Drugs)IBA
02/2014 - 01/2004
2Coloring Agents (Dyes)IBA
01/2014 - 02/2010
2nitazoxanide (NTZ)FDA Link
08/2012 - 03/2009
2Synthetic Vaccines (Recombinant Vaccines)IBA
04/2011 - 04/2006
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1albendazole sulfoxideIBA
11/2019
1InterferonsIBA
11/2017
1InterleukinsIBA
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2017
1Matrix Metalloproteinases (MMPs)IBA
11/2017
1Peptide Hydrolases (Proteases)FDA Link
11/2017
1AngiopoietinsIBA
11/2017
1Metalloproteases (Metalloproteinases)IBA
11/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2017
1Etanercept (Enbrel)FDA Link
11/2017
1Contrast MediaIBA
01/2016
1TriclabendazoleIBA
01/2016
1Capsules (Microcapsules)IBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
03/2015
1Prednisone (Sone)FDA LinkGeneric
08/2012
1Indicators and Reagents (Reagents)IBA
04/2012
1Eosine Yellowish-(YS) (Eosin)IBA
02/2010
1Drug CombinationsIBA
02/2010
1DNA (Deoxyribonucleic Acid)IBA
07/2008
1Glutathione Transferase (Glutathione S-Transferase)IBA
02/2008
1NF-kappa B (NF-kB)IBA
06/2006
1EpitopesIBA
05/2006
1DisulfidesIBA
05/2006
1Cathartics (Purgatives)IBA
03/2004
1PlacebosIBA
01/2004

Therapy/Procedure

8Therapeutics
11/2019 - 10/2002
5Aftercare (After-Treatment)
11/2021 - 01/2004
1Retreatment
11/2021
1Mass Drug Administration
01/2021
1Immunomodulation
02/2012